Published in Clin Exp Hypertens on October 24, 1996
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | NCT00000542
Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol (1985) 17.42
Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension (1995) 10.38
Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol (1983) 10.23
Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension (1995) 6.48
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA (1993) 6.27
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am J Epidemiol (1995) 4.62
Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol (1985) 4.52
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia (2005) 4.19
H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol (1985) 3.91
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med (1984) 3.88
Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA (1992) 3.86
Atypical biogroups of Escherichia coli found in clinical specimens and description of Escherichia hermannii sp. nov. J Clin Microbiol (1982) 3.84
Trial of calcium to prevent preeclampsia. N Engl J Med (1997) 3.69
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Characterization of biochemically atypical Vibrio cholerae strains and designation of a new pathogenic species, Vibrio mimicus. J Clin Microbiol (1981) 3.19
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98
Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med (1992) 2.96
High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun (1982) 2.95
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis (1987) 2.77
Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med (1996) 2.62
Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med (1991) 2.49
Extrachromosomal nature of hydrogen sulfide production in Escherichia coli. J Bacteriol (1971) 2.45
Differential effect of steady versus oscillating flow on bone cells. J Biomech (1998) 2.38
Correlation between adherence to HeLa cells and serogroups, serotypes, and bioserotypes of Escherichia coli. Infect Immun (1985) 2.28
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care (2000) 2.22
Enterotoxin-producing Escherichia coli and diarrheal disease in adult travelers: a prospective study. J Infect Dis (1974) 2.19
Change in physician perspective on cholesterol and heart disease. Results from two national surveys. JAMA (1987) 2.17
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA (1997) 2.11
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design. Hypertension (1991) 2.04
Trends in pharmacologic management of hypertension in the United States. Arch Intern Med (1995) 2.04
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J (2002) 1.98
Change in public perspective on cholesterol and heart disease. Results from two national surveys. JAMA (1987) 1.98
Physical exercise and the prevention of disability in activities of daily living in older persons with osteoarthritis. Arch Intern Med (2001) 1.94
Biochemical and serological characterization of hydrogen sulfide-positive variants of Escherichia coli. Appl Microbiol (1974) 1.89
Visual acuity of eyes after vitrectomy for retinopathy of prematurity: follow-up at 5 1/2 years. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology (1996) 1.87
Response of rat lung to 3,4-benzpyrene administered by intratracheal instillation in infusine with or without carbon black. Br J Cancer (1975) 1.86
Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA (1987) 1.86
Isolated systolic hypertension : prognostic information provided by pulse pressure. Hypertension (1999) 1.83
High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr (1998) 1.82
Detection of Serratia outbreaks in hospital. Lancet (1976) 1.81
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation (2001) 1.78
Em polypeptide and its messenger RNA levels are modulated by abscisic acid during embryogenesis in wheat. Eur J Biochem (1985) 1.78
Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis. Proc Natl Acad Sci U S A (1987) 1.72
Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med (1996) 1.72
A multistate outbreak of infections caused by Yersinia enterocolitica transmitted by pasteurized milk. JAMA (1984) 1.70
Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation (2001) 1.68
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation (1998) 1.63
Use of a new buffer in the culture of animal cells. J Gen Virol (1968) 1.57
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia (2012) 1.57
A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study. Clin Cardiol (1999) 1.52
The purification and characterization of an extremely thermostable alpha-amylase from the hyperthermophilic archaebacterium Pyrococcus furiosus. J Biol Chem (1993) 1.52
Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension (1998) 1.51
Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med (1982) 1.50
Functional decline in older adults: expanding methods of ascertainment. J Gerontol A Biol Sci Med Sci (1996) 1.49
Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med (1998) 1.49
Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations. J Virol (1986) 1.47
Association of muscle strength with maximum walking speed in disabled older women. Am J Phys Med Rehabil (1998) 1.46
Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Ann Intern Med (1990) 1.46
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. Control Clin Trials (2001) 1.39
Toxigenic Vibrio cholerae O1 strain from Mexico identical to United States isolates. Lancet (1983) 1.39
Fatal cutaneous necrosis mimicking calciphylaxis in a patient with type 1 primary hyperoxaluria. Arch Dermatol (1995) 1.39
Characterization of a causative mutation of hemophilia A identified in the promoter region of the factor VIII gene (F8). J Thromb Haemost (2007) 1.38
Ureolytic Escherichia coli of human origin: serological, epidemiological, and genetic analysis. J Clin Microbiol (1979) 1.35
Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA (1996) 1.33
Visual acuity in infants after vitrectomy for severe retinopathy of prematurity. Ophthalmology (1991) 1.31
Roles for mannitol and mannitol dehydrogenase in active oxygen-mediated plant defense. Proc Natl Acad Sci U S A (1998) 1.26
Predicting future years of healthy life for older adults. J Clin Epidemiol (1998) 1.26
Hemolytic activity in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli. J Clin Microbiol (1980) 1.25
Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation (1993) 1.23
"Enteropathogenic serotypes" of Escherichia coli which really are not. J Pediatr (1977) 1.22
Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group. Hypertension (1993) 1.22
Disease from infection with Vibrio mimicus, a newly recognized Vibrio species. Clinical characteristics and edipemiology. Ann Intern Med (1983) 1.21
Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med (1997) 1.20
Financial difficulty in acquiring food among elderly disabled women: results from the Women's Health and Aging Study. Am J Public Health (2001) 1.19
Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT). Circulation (1996) 1.18
Recruitment of participants for the multiple risk factor intervention trial (MRFIT). Control Clin Trials (1987) 1.18
Calcium-channel blockers for hypertension--uncertainty continues. N Engl J Med (1998) 1.17
Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke (1989) 1.17
Purification of NAD-dependent mannitol dehydrogenase from celery suspension cultures. Plant Physiol (1995) 1.17
Serological comparison of two collections of Vibrio cholerae non O1. J Clin Microbiol (1982) 1.14
Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol (1997) 1.13
Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Control Clin Trials (2001) 1.12